Category Legend

Study Type(s)

Topic Area(s)

Document Type(s)

Study Method(s)

Document Method(s)

COHSONET: Social Network TB Codebook (1342)

COHSONET TB participant social network form codebook.

Project nGage: Fidelity Assessment Checklist (1200)

Study staff fidelity checklist for Project nGage study.

Project nGage: Intervention Manual (1199)

Intervention Manual for Project nGage; akin to a broad SOP/protocol with surveys for study staff. Includes overview, baseline visit details, Session I: identifying network support and engaging support confidant, Module A: support matters! Providing support for young people living with HIV, PIE worksheet, Module B: motivating social support, Module C: information is power, essential information about HIV and AIDS, what happens at the clinic, HIV medications and adherence, common barriers to taking medications and attending appointments, Session II Module D: personalized care and support plan with worksheet, barriers and solutions worksheets, telephone follow-up sessions for index-support confidant dyads with scripts, references.

Project WERK: Intervention Manual (1196)

Intervention Manual for Project WERK; akin to a broad SOP/protocol with surveys and interview guides for study staff.

PrEP Up Pharmacies: Survey (1175)

Full Survey for PrEP Up Pharmacies study, includes sections on well-being, demographics, relationship status, education, income, insurance coverage, homelessness, PrEP, sexual behaviors, drugs and alcohol, pharmacy experience, health care services, health services in this pharmacy, injectable PrEP, social experiences, mental health, review.

HIV Care Continuum Avatar App: 6 Month Follow-Up Questionnaire (1118)

6-month follow up questionnaire including demographic information, education, employment, marital status, income, sexual orientation, height and weight, depression and anxiety, resiliency, social support, health literacy, substance use, care entry, adherence, retention in care, housing stability, incarceration, phone and health apps, and food safety questions for the Avatar App Study.

PrEP@Home: Baseline Survey (1108)

Baseline survey including demographics, gender identity, race and ethnicity, education, employment, healthcare coverage, health access and engagement, health literacy, acute symptoms, marital status, HIV/STI testing history, sexual history, basic HIV knowledge, perceived HIV risk, PEP awareness, PrEP knowledge/attitudes, PrEP intentions, PrEP stigma, sexual stigma, outness to provider, mental health, resiliency, substance use, willingness to pay, income, housing stability, and use of social/geosocial networking sites for the PrEP@Home Study.

PrEP@Home: Follow up Survey (1106)

Follow-up survey including adherence, side effects, acute symptoms, sexual history, PrEP stigma, PHQ-2/GAS-2 screener, substance use, CAGE-AID questions, housing, SUS, healthcare coverage, cost, and use of social/geosocial networking sites for the PrEP@Home Study.

PrEP@Home: Enrollment SOP (1098)

Enrollment SOP describing how staff handles the enrollment process for all participants in the PrEP@Home Study, including study visit eligibility, baseline visit, enrollment, and randomization.

PrEP@Home: Retention Plan SOP (1097)

SOP for participant retention plans, including retention coordinator roles and responsibilities, baseline appointment scheduling scripts, follow-up care kit and appointment reminders, example message scripts, and change of status at the end of the study for the PrEP@Home Study.

PrEP@Home: Protocol (1080)

Expanded standard protocol including introduction, methods, study overview, study intervention, trial design, procedures, laboratory specimens and procedures, safety monitoring and adverse event reporting, statistical considerations, human subjects considerations, administrative procedures, and references for the PrEP@Home Study.

PrEP@Home: Division of AIDS (DAIDS) Table for Grading the Severity of Adult & Pediatric Adverse Events CRF (1062)

CRF from Division of AIDS (DAIDS), U.S. Department of Health and Human Services: Severity grading table for adult and pediatric adverse events for the PrEP@Home Study.